Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
LeonaBio President and CEO Mark James Litton reported a sale of 5,156 shares on March 4, 2026, raising $27,687 at a weighted-average price of $5.37 per share after exercising options the prior day. The transaction comes amid corporate restructuring, a major licensing deal for lasofoxifene and fresh financing and analyst coverage that have shaped ma…
MiniMed Group, Inc., a unit of Medtronic plc (MDT), has priced its initial public offering at $20.00 per share for 28 million shares, equating to $560 million in gross proceeds before fees and expenses. The company is slated to begin trading on the Nasdaq Global Select Market on March 6, 2026 under the ticker MMED, with the transaction expected to …
Beta Bionics NASDAQ:BBNX Chief Commercial Officer Hopman Mark sold 353 shares on March 4, 2026, at $11.57 per share for about $4,084. The transaction was executed under a Rule 10b5-1 plan adopted May 13, 2025, and was disclosed in a Form 4 filing. The stock has fallen 12% over the past week and is down 64% year-to-date. Analysts continue to offer d…
Timothy R. Barakett, a director at KKR & Co. Inc., purchased 50,000 shares of common stock on March 4, 2026, for roughly $4.72 million. The trade comes amid a quarter in which KKR missed consensus adjusted EPS and as the firm pursues potential disposals and strategic partnerships, including a possible sale of BMC Helix and talks about a renewable-e…
Stephen L. Rohde, a director at Slide Insurance Holdings, Inc. (NYSE: SLDE), sold 10,000 shares across March 3 and March 4, 2026, for about $193,300 and simultaneously exercised options to buy 10,000 shares for $0.0018 each. The transactions occurred as SLDE stock has risen 42% over six months and after the company reported a sizable fourth-quarter…
Voss Capital and affiliated vehicles purchased $14.6 million of PAR Technology (NASDAQ: PAR) shares between January 14 and February 4, 2026, paying between $22.1999 and $39.1047 per share. The trades increased Voss-linked direct holdings and included several call option purchases. The activity comes as PAR shares trade at $19.52, down 68% over the …
Matthew Paul Larson, Chief Risk Officer of Slide Insurance Holdings Inc. (NASDAQ:SLDE), sold 11,250 shares on March 3, 2026, for roughly $213,862 and concurrently exercised options on 11,250 shares at $0.79 per share. The moves were disclosed in a Form 4 filing and occur amid solid quarterly results and valuation metrics showing SLDE trading at a P…
Castle Biosciences Inc (NASDAQ:CSTL) Chief Financial Officer Frank Stokes sold 7,000 shares on March 3, 2026, in two tranches that generated roughly $192,073. Around the same time he sold additional shares to cover taxes and exercised options to acquire nearly 28,000 shares while receiving 48,367 restricted stock units. The activity coincides with …
LeonaBio, Inc. (NASDAQ: LONA) reported a modest insider sale by Chief Financial Officer Robert Renninger tied to taxes on vested restricted stock units, alongside disclosures that include option exercises and a remaining direct holding of 15,851 shares. The company is navigating a strategic pivot toward oncology with licensed global rights for laso…
Ryan Cohlhepp, President and COO of Bicara Therapeutics Inc. (BCAX), sold 17,392 shares on March 3, 2026, for about $315,892 and concurrently exercised options to acquire 12,892 shares. The transactions were carried out under a Rule 10b5-1 plan adopted February 12, 2025. Bicara has recently completed a large stock offering and received an analyst r…
President Donald Trump has named Senator Markwayne Mullin of Oklahoma to head the Department of Homeland Security, a post that will require confirmation by the U.S. Senate. Mullin, a former mixed martial arts fighter and plumbing business owner turned lawmaker, will replace Kristi Noem, whose tenure has been clouded by bipartisan criticism over a $…
Intuitive Surgical's SVP and head of manufacturing and supply chain, Brosius Mark, sold 3,658 shares of company stock in three transactions between March 3 and March 5, 2026, for a total of $1,815,061. The disposals were carried out under a Rule 10b5-1 trading plan set to expire February 14, 2027. Separately, the company reported robust fourth-quar…
Boeing is facing a confluence of weak deliveries, higher operational disruption from geopolitical events and a valuation that assumes continued operational recovery. The technicals are bearish, free cash flow is negative, and short activity is elevated. We lay out a mid-term (45 trading days) short trade with clear entry, stop and target, plus cata…
Northern Trust Executive Vice President and Chief Financial Officer David W. Fox Jr. sold 3,255 shares on March 4, 2026, for $468,361. The transaction comes as the company reported stronger fourth-quarter 2025 results and multiple brokerages raised price targets. Fox's remaining direct and indirect holdings are detailed in a Form 4 filing.
Director Richard W. Fisher sold 16,345 shares of Warner Bros. Discovery (WBD) Series A common stock on March 3, 2026, generating about $462,726. The sale occurred as the stock has seen significant recent gains but is flagged as overvalued by InvestingPro. The transaction takes place against a backdrop of merger and deal activity, including Paramoun…
A proposed $7.25 billion class action settlement over claims that the weedkiller Roundup causes cancer contains provisions designed to discourage individual claimants and their lawyers from rejecting the deal. The agreement, preliminarily approved by a Missouri state court, withholds fees from lawyers who continue representing more than 25 clients …
A federal judge has directed the U.S. government to begin reimbursing importers for emergency tariffs imposed during the Trump administration that the U.S. Supreme Court ruled unlawful in late February. Budget analysts estimate the refunds could total between $168 billion and $182 billion. The mechanism for distributing those refunds remains unclea…
Will W Anthony, formerly president and CEO of CF Industries, sold 64,273 shares of common stock on March 3, 2026, in two transactions totaling about $7,009,894. After the sales Anthony retains direct ownership of 194,010 shares. The trades come while CF Industries shares trade near a 52-week high and after the company reported robust fourth-quarter…
SFS Holding Corp., an entity through which Mat Ishbia indirectly holds shares, sold 1,898,622 Class A shares of UWM Holdings Corp (NASDAQ: UWMC) across three transactions from March 3-5, 2026, generating roughly $7.9 million in proceeds. The trades were executed under a 10b5-1 plan adopted in September 2025. The sales occur against a backdrop of re…
NPEH, LLC, a 10% holder of NET Power Inc. (NYSE: NPWR), disposed of 100,000 Class A shares on March 3, 2026, receiving $204,250 for the stock sold at prices between $2.01 and $2.015. The transaction leaves NPEH with 400,000 directly held shares. NET Power has fallen roughly 70% over the past year and is trading near a 52-week low of $1.48; earnings…
Joseph Loscalzo, a member of Ionis Pharmaceuticals' board, sold 1,032 shares in early March 2026 for roughly $82,832 and simultaneously exercised options to acquire the same number of shares at $38.06. The transactions coincide with a flurry of regulatory and clinical activity at the biotech, including an FDA acceptance of a supplemental NDA for ol…
Ionis Pharmaceuticals director Joseph Klein III sold 21,332 shares on March 3, 2026 for roughly $1.7 million, with transaction prices between $79.174 and $80.818. He also exercised options to acquire 16,000 shares at strike prices of $40.05 and $42.88, valued at $652,120. After the trades, Klein owns 11,014 shares directly and his son holds 100 sha…
Shannon L. Devers, Executive Vice President and Chief Human Resources Officer at Ionis Pharmaceuticals, sold 20,006 shares on March 3, 2026, for about $1.59 million after exercising options to acquire the same number of shares. The company recently secured FDA Priority Review for olezarsen with a target action date of June 30, 2026, and will presen…
Allene M. Diaz, a director at Ionis Pharmaceuticals, sold $4.35 million of company stock on March 3, 2026, and exercised options to acquire an additional 40,321 shares. The transactions occurred under a Rule 10b5-1 plan and follow a period of strong one-year performance for the stock. Separately, Ionis has an FDA decision pending for olezarsen and …
C. Frank Bennett, Executive Vice President and Chief Scientific Officer of Ionis Pharmaceuticals (IONS), sold 85,089 shares on March 3, 2026, generating roughly $6.74 million in proceeds. Bennett also exercised options to acquire 65,089 shares at strike prices of $32.6 and $60.89, costing $3,497,530. After the transactions he directly holds 80,554 …
